Announcements

16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China


MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

  • Biomedicines;
  • Cancers;
  • Cells;
  • Diagnostics;
  • Current Oncology;
  • JPM;
  • JCM;
  • Onco;
  • CIMB;
  • BioMedInformatics.

If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

24 November 2022
Editorial Board Members from Diagnostics Featured in 2022 Highly Cited Researchers List Published by Clarivate

Recently, ClarivateTM revealed its 2022 list of Highly Cited Researchers™—individuals at universities, research institutes and commercial organizations.

The scientists who were selected into this year’s list of Highly Cited Researcher have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.

According to statistics, three members of the Editorial Board of Diagnostics (ISSN: 2075-4418) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. Diagnostics journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.

Name Affiliation
Prof. Dr. Giuseppe Lippi University of Verona, Italy
Dr. Ramanan Laxminarayan Princeton University, United States
Prof. Dr. Alessandro Russo University of Milano-Bicocca, Italy

9 November 2022
Editorial Board Members from Diagnostics Featured in Stanford’s List of the World’s Top 2% Scientists

Stanford University has recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 114 Editorial Boards Members from MDPI Diagnostics (ISSN: 2075-4418) were featured in Stanford University World’s Top 2% Scientists list in 2022.

Name Affiliation
Prof. Dr. Abass Alavi Hospital of the University of Pennsylvania
Prof. Dr. Ahsan Khandoker Khalifa University of Science and Technology
Prof. Dr. Alberto Stefano Tagliafico Università degli Studi di Genova
Dr. Alberto Trinchieri Università degli Studi di Milano
Prof. Dr. Aldo Quattrone Università degli studi Magna Graecia di Catanzaro
Prof. Dr. Anastasios Koulaouzidis Pomeranian Medical University in Szczecin
Prof. Dr. Andor W.J.M. Glaudemans Universitair Medisch Centrum Groningen
Dr. Andrea Angelini Università degli Studi di Padova
Dr. Andrea Mazzanti Università degli Studi di Pavia
Prof. Dr. Andreas Kjaer Københavns Universitet
Dr. Andrew Churg The University of British Columbia
Dr. Andrew Macnab The University of British Columbia
Prof. Dr. Antonella Santone Università degli Studi del Molise
Prof. Dr. Antonio Amoroso Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino
Prof. Dr. Antonio Barile Università degli Studi dell'Aquila
Prof. Dr. Antonio Farina IRCCS Azienda Ospedaliero-Universitaria di Bologna
Dr. Ayumi Yoshizaki Graduate School of Medicine
Prof. Dr. Chong Hyun Suh University of Ulsan College of Medicine
Prof. Dr. Christoph Palm Ostbayerische Technische Hochschule Regensburg
Prof. Dr. Christopher Kai Shun Leung Chinese University of Hong Kong
Prof. Dr. Dah Ching Ding Tzu Chi University
Prof. Dr. Daniel Fried University of California, San Francisco
Prof. Dr. Denisa Muraru Università degli Studi di Milano-Bicocca
Prof. Dr. Einat Even-Sapir Tel Aviv University
Prof. Dr. Elina A. Genina Saratov State University
Prof. Dr. Emanuela Turillazzi Università di Pisa
Prof. Dr. Emanuele Neri Università di Pisa
Prof. Dr. Evangelos Terpos School of Medicine
Prof. Dr. Evangelyn Alocilja Michigan State University
Dr. Fahmi Khalifa University of Louisville
Dr. Felix G. Meinel Universität Rostock Uniklinikum und Medizinische Fakultät
Prof. Dr. Francesco Giammarile International Atomic Energy Agency, Vienna
Prof. Dr. Francesco Paolo Busardò Università Politecnica delle Marche
Prof. Dr. Frank W. Roemer Boston University School of Medicine
Dr. Gabriele Masselli Sapienza Università di Roma
Prof. Dr. Gaetano Magro Università degli Studi di Catania, Scuola di Medicina
Dr. Gerald J. Kost UC Davis School of Medicine
Dr. Gernot Hudelist Hospital St. John of God
Prof. Dr. Gian Luca Salvagno Università degli Studi di Verona
Prof. Dr. Gianpaolo Carrafiello Ospedale Maggiore Policlinico Milano
Prof. Dr. Gilbert Donders Universitair Ziekenhuis Antwerpen
Prof. Dr. Giorgio Bellomo Università degli Studi del Piemonte Orientale Amedeo Avogadro
Prof. Dr. Giovanna Ferraioli Università degli Studi di Pavia, Facoltà di Medicina e Chirurgia
Dr. Giulia Bivona Università degli Studi di Palermo
Prof. Dr. Giuseppe Lippi Università degli Studi di Verona
Prof. Dr. Habib Zaidi Hôpitaux Universitaires de Genève
Prof. Dr. Hajime Isomoto Tottori University Faculty of Medicine
Prof. Dr. Hatem Alkadhi UniversitatsSpital Zurich
Prof. Dr. Isabella Castiglioni Università degli Studi di Milano-Bicocca
Prof. Dr. Ivan Fan Ngai Hung The University of Hong Kong Li Ka Shing Faculty of Medicine
Prof. Dr. Ja Hyeon Ku Seoul National University Hospital
Prof. Dr. Jacques Marescaux IRCAD Institut de Recherche contre les Cancers de l'Appareil Digestif
Dr. Jan Poelaert Universitair Ziekenhuis Brussel
Dr. Jasjit S. Suri AtheroPoint™
Prof. Dr. Jeewon Lee Korea University
Dr. Ju Dong Yang Cedars-Sinai Medical Center
Dr. Kazushi Numata Yokohama City University Medical Center
Prof. Dr. Kazutaka Kamiya Kitasato University
Prof. Dr. Kefah Mokbel Princess Grace Hospital
Prof. Dr. Kenji Suzuki Tokyo Institute of Technology
Prof. Dr. Letterio S. Politi Humanitas Research Hospital
Prof. Dr. Luca Morelli Università di Pisa
Prof. Dr. Luca Saba Azienda Ospedaliero Universitaria di Cagliari
Prof. Dr. Marcello Ciaccio Università degli Studi di Palermo
Prof. Dr. Marco Salvatore IRCCS Fondazione SDN
Prof. Dr. María Carmen Blanco-López Universidad de Oviedo
Dr. Mario Damiano Toro Medical University of Lublin
Prof. Dr. Markos G. Tsipouras University of Western Macedonia
Prof. Dr. Massimiliano Calabrese Università degli Studi di Verona
Dr. Matteo Ferro Istituto Europeo di Oncologia
Prof. Dr. Maurilio Ponzoni IRCCS Ospedale San Raffaele
Dr. May C. Morris Université de Montpellier
Prof. Dr. Michel Meignan Hôpital Henri Mondor
Prof. Dr. Najib Haboubi Spire Manchester Hospital
Prof. Dr. Nathalie Lassau Universite Paris-Saclay
Prof. Dr. Oke Gerke Odense Universitetshospital
Prof. Dr. Pablo Yagupsky Soroka University Medical Center
Dr. Paola Ulivi Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Prof. Dr. Paolo Zamboni University of Ferrara
Dr. Paul E. Sijens Universitair Medisch Centrum Groningen
Prof. Dr. Paul Froom Tel Aviv University
Dr. Philippe A. Grenier Hopital Foch
Dr. Qiwei Tian Shanghai University of Medicine & Health Sciences
Dr. Rachel Bar-Shalom Shaare Zedek Medical Center
Prof. Dr. Raffaele Nardone Hospital of Merano (SABES-ASDAA)
Dr. Ramanan Laxminarayan Princeton University
Dr. Raul Colodner Emek Medical Center
Prof. Dr. Ravindra K. Pandey Roswell Park Cancer Institute
Prof. Dr. Riemer H. J. A. Slart Universitair Medisch Centrum Groningen
Prof. Dr. Robert Lemoyne Northern Arizona University
Prof. Dr. Romaric Loffroy Hôpital François Mitterrand
Dr. Rüdiger Emshoff Medizinische Universitat Innsbruck
Dr. Salvatore Giovanni Vitale Università degli Studi di Catania
Dr. Sameer Antani National Institutes of Health (NIH)
Prof. Dr. Sergio Harari Università degli Studi di Milano
Dr. Silvia Morbelli IRCCS San Martino Polyclinic Hospital
Prof. Dr. Søren Møller Faculty of Health and Medical Sciences
Dr. Soroush Rais-Bahrami The University of Alabama at Birmingham
Prof. Dr. Stefan Holdenrieder Deutsches Herzzentrum München
Prof. Dr. Stefania Mondello Università degli Studi di Messina
Dr. Stefano Ghio Fondazione IRCCS Policlinico San Matteo
Dr. Subba R. Digumarthy Massachusetts General Hospital
Prof. Dr. Sung Chul Lim Chosun University
Dr. Sung Ho Jang School of Medicine
Dr. Takashi Kojima Keio University School of Medicine
Dr. Tanveer Syeda-Mahmood IBM Research - Almaden
Dr. Theodoros D. Karamitsos Aristotle University of Thessaloniki
Prof. Dr. Timo Sorsa Helsingin Yliopisto
Prof. Dr. Toshitaka Nagao Tokyo Medical University
Dr. Xavier Bosch Universitat de Barcelona
Prof. Dr. Zeno Bisoffi Università degli Studi di Verona
Prof. Dr. Zhen Cheng Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Dr. Zhenyu Liu Institute of Automation Chinese Academy of Sciences
Prof. Dr. Zhongheng Zhang Sir Run Run Shaw Hospital

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Diagnostics.

4 November 2022
Meet Us at the 27th Congress of the Chinese Pediatric Society, 15–18 December 2022, Changsha, China

MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.

27th Congress of Chinese Pediatric Society

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have. 

For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.

Back to TopTop